Monocyte-expressed urokinase inhibits vascular smooth muscle cell growth by activating Stat1
Authors:
- 15 December 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 102 (13) , 4377-4383
Abstract
After vascular injury, a remodeling process occurs that features leukocyte migration and infiltration. Loss of endothelial integrity allows the leukocytes to interact with vascular smooth muscle cells (VSMCs) and to elicit “marching orders”; however, the signaling processes are poorly understood. We found that human monocytes inhibit VSMC proliferation and induce a migratory potential. The monocytes signal the VSMCs through the urokinase-type plasminogen activator (uPA). The VSMC uPA receptor (uPAR) receives the signal and activates the transcription factor Stat1 that, in turn, mediates the antiproliferative effects. These results provide the first evidence that monocytes signal VSMCs by mechanisms involving the fibrinolytic system, and they imply an important link between the uPA/uPAR-related signaling machinery and human vascular disease. (Blood. 2003;102: 4377-4383)Keywords
This publication has 40 references indexed in Scilit:
- Roles of Phosphatidylinositol 3-Kinase in Interferon-γ-dependent Phosphorylation of STAT1 on Serine 727 and Activation of Gene ExpressionJournal of Biological Chemistry, 2001
- Characterization of a G Protein-activated Phosphoinositide 3-Kinase in Vascular Smooth Muscle Cell NucleiJournal of Biological Chemistry, 2001
- Urokinase Stimulates Human Vascular Smooth Muscle Cell Migration via a Phosphatidylinositol 3-Kinase-Tyk2 InteractionJournal of Biological Chemistry, 2000
- Signaling pathways activated by interferonsExperimental Hematology, 1999
- The Proliferative Effect of Vascular Endothelial Growth Factor Requires Protein Kinase C-α and Protein Kinase C-ζArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Prevention of RestenosisTrends in Cardiovascular Medicine, 1997
- STATs: Signal Transducers and Activators of TranscriptionCell, 1996
- Mechanism by Which U937 Promonocytic Cells Inactivate Human Interferon-γJournal of Interferon & Cytokine Research, 1995
- Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six monthsThe Lancet, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993